Intratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases. [electronic resource]
Producer: 20201016Description: 332-339 p. digitalISSN:- 1090-2104
- Animals
- Cell Line
- Enzyme Activation -- drug effects
- Exenatide -- adverse effects
- Glucagon-Like Peptide-1 Receptor -- metabolism
- Hypoglycemic Agents -- adverse effects
- Lung Diseases, Obstructive -- drug therapy
- Mice, Inbred C57BL
- Mucins -- genetics
- Up-Regulation -- drug effects
- p38 Mitogen-Activated Protein Kinases -- metabolism
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.